These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 7010380

  • 21. Selective deficiency in pneumococcal antibody response in children with recurrent infections.
    Epstein MM, Gruskay F.
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):125-31. PubMed ID: 7648376
    [Abstract] [Full Text] [Related]

  • 22. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.
    Dagan R, Givon-Lavi N, Shkolnik L, Yagupsky P, Fraser D.
    J Infect Dis; 2000 Apr; 181(4):1322-9. PubMed ID: 10753730
    [Abstract] [Full Text] [Related]

  • 23. Acute otitis media.
    Klein JO, Bluestone CD.
    Pediatr Infect Dis; 1982 Apr; 1(1):66-73. PubMed ID: 7177897
    [No Abstract] [Full Text] [Related]

  • 24. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF.
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [Abstract] [Full Text] [Related]

  • 25. Antibody responses to pneumococcal capsular polysaccharide: what is being measured?
    Goldblatt D, Jadresic LP, Levinsky RJ, Turner MW.
    Immunodeficiency; 1993 Jun; 4(1-4):47-50. PubMed ID: 8167732
    [No Abstract] [Full Text] [Related]

  • 26. Potential of bacterial vaccines in the prevention of acute otitis media.
    Eskola J, Kilpi T.
    Pediatr Infect Dis J; 2000 May; 19(5 Suppl):S72-8. PubMed ID: 10821475
    [No Abstract] [Full Text] [Related]

  • 27. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media.
    Joloba ML, Windau A, Bajaksouzian S, Appelbaum PC, Hausdorff WP, Jacobs MR.
    Clin Infect Dis; 2001 Nov 01; 33(9):1489-94. PubMed ID: 11588694
    [Abstract] [Full Text] [Related]

  • 28. The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?
    Dagan R.
    Vaccine; 2008 Jun 16; 26 Suppl 2():B16-8. PubMed ID: 18793601
    [Abstract] [Full Text] [Related]

  • 29. Beneficial effect of pneumococcal vaccination on otitis media in children over two years old.
    Rosén C, Christensen P, Henrichsen J, Hovelius B, Prellner K.
    Int J Pediatr Otorhinolaryngol; 1984 Jul 16; 7(3):239-46. PubMed ID: 6480233
    [Abstract] [Full Text] [Related]

  • 30. A pneumococcal conjugate vaccine for infants and children.
    Med Lett Drugs Ther; 2000 Mar 20; 42(1074):25-7. PubMed ID: 10776409
    [No Abstract] [Full Text] [Related]

  • 31. Brief review of the clinical effectiveness of PREVENAR against otitis media.
    Fletcher MA, Fritzell B.
    Vaccine; 2007 Mar 22; 25(13):2507-12. PubMed ID: 17011085
    [Abstract] [Full Text] [Related]

  • 32. Bacterial otitis media: a vaccine preventable disease?
    Cripps AW, Otczyk DC, Kyd JM.
    Vaccine; 2005 Mar 18; 23(17-18):2304-10. PubMed ID: 15755616
    [Abstract] [Full Text] [Related]

  • 33. Development of antibodies against the putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media.
    Bogaert D, Holmlund E, Lahdenkari M, de Groot R, Kilpi T, Hermans PW, Kayhty H.
    FEMS Immunol Med Microbiol; 2006 Mar 18; 46(2):166-8. PubMed ID: 16487297
    [Abstract] [Full Text] [Related]

  • 34. [Serological and clinical response to pneumococcal vaccine].
    Beer S, Laver J, Heyman E, Kaufman A, Karpuch H, Schwartz T, Vure E.
    Harefuah; 1981 Jan 15; 100(2):59-61. PubMed ID: 7262654
    [No Abstract] [Full Text] [Related]

  • 35. Serotype distribution of Streptococcus pneumoniae in north-western Greece and implications for a vaccination programme.
    Levidiotou S, Vrioni G, Tzanakaki G, Pappa C, Gesouli H, Gartzonika C, Papamichail D, Kremastinou J.
    FEMS Immunol Med Microbiol; 2006 Nov 15; 48(2):179-82. PubMed ID: 17064274
    [Abstract] [Full Text] [Related]

  • 36. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740].
    Rodgers GL, Arguedas A, Cohen R, Dagan R.
    Vaccine; 2009 Sep 04; 27(40):5429-30. PubMed ID: 19643215
    [No Abstract] [Full Text] [Related]

  • 37. Antibody activity before and after pneumococcal vaccination of otitis-prone and non-otitis-prone children.
    Kalm O, Prellner K, Freijd A, Rynnel-Dagöö B.
    Acta Otolaryngol; 1986 Sep 04; 101(5-6):467-74. PubMed ID: 3727981
    [Abstract] [Full Text] [Related]

  • 38. Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs.
    Weycker D, Richardson E, Oster G.
    Am J Manag Care; 2000 Jul 04; 6(10 Suppl):S526-35. PubMed ID: 11183904
    [Abstract] [Full Text] [Related]

  • 39. Otitis media. A scholarly review of the evidence.
    Pappas DE, Owen Hendley J.
    Minerva Pediatr; 2003 Oct 04; 55(5):407-14. PubMed ID: 14608264
    [Abstract] [Full Text] [Related]

  • 40. The role of antibodies to pneumococcal C polysaccharide in otitis media.
    Henrichsen J, Sørensen CH.
    Pediatr Infect Dis J; 1989 Jan 04; 8(1 Suppl):S26-7. PubMed ID: 2927979
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.